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Background: In-hospital case-fatality rates in patients, admitted for acute myocardial infarction (AMI-CFRs), are
internationally used as a quality indicator. Attempting to encourage the hospitals to assume responsibility, the
Belgian Ministry of Health decided to stimulate initiatives of quality improvement by means of a limited set of
indicators, among which AMI-CFR, to be routinely analyzed. In this study we aimed, by determining the existence
of inter-hospital differences in AMI-CFR, (1) to evaluate to which extent Belgian discharge records allow the
assessment of quality of care in the field of AMI, and (2) to identify starting points for quality improvement.
Methods: Hospital discharge records from all the Belgian short-term general hospitals in the period 2002-2005. The
study population (N = 46,287) included patients aged 18 years and older, hospitalized for AMI. No unique patient
identifier being present, we tried to track transferred patients. We assessed data quality through a comparison of
MCD with data from two registers for acute coronary events and through transfer and sensitivity analyses. We
compared AMI-CFRs across hospitals, using multivariable logistic regression models. In the main model hospitals,
Charlson’s co-morbidity index, age, gender and shock constituted the covariates. We carried out two types of
analyses: a first one wherein transferred-out cases were excluded, to avoid double counting of patients when
computing rates, and a second one with exclusion of all transferred cases, to allow the study of patients admitted
into, treated in and discharged from the same hospital.
Results: We identified problems regarding both the CFR’s numerator and denominator.
Sensitivity analyses revealed differential coding and/or case management practices. In the model with exclusion of
transfer-out cases, the main determinants of AMI-CFR were cardiogenic shock (ORadj 23.0; 95% CI [20.9;25.2]), and
five-year age groups ORadj 1.23; 95% CI [1.11;1.36]). Sizable inter-hospital and inter-type of hospital differences
{(ORcomunity vs tertiary hospitals1.36; 95% CI [1.34;1.39]) and (ORintermediary vs tertiary hospitals1.36; 95% CI [1.34;1.39])}, and
nonconformities to guidelines for treatment were observed.
Conclusions: Despite established data quality shortcomings, the magnitude of the observed differences and the
nonconformities constitute leads to quality improvement. However, to measure progress, ways to improve and
routinely monitor data quality should be developed.
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Acute Myocardial Infarction (AMI) is a health problem
of paramount importance in terms of frequency, ser-
iousness, social and economic costs, amenability to med-
ical intervention and priority-ranking by policy makers
and the community [1,2]. Although guidelines that
effectively reduce AMI in-hospital case-fatality rates
(AMI-CFRs) exist, they are not uniformly applied [3-7].
Conversely, reports of AMI-CFRs were thought to favor-
ably affect quality initiatives [8]. The relationship
between better care and lower AMI-CFRs led several
countries, national and international agencies, and con-
sumer’s organizations to select AMI-CFR as a quality
indicator and to publish individual providers’ rates
[3,9-11].
To organize the care of AMI patients in Belgium, a
three-level structure has been set up. It consists of com-
munity hospitals (labeled A) having no catheterization
facility, intermediary hospitals (labeled B1) providing
coronary angiography but no Percutaneous Coronary
Intervention (PCI), and tertiary hospitals (labeled B2-B3)
offering PCI and/or Coronary Artery Bypass Graft. A
recent study, however, showed unable to establish better
outcomes for patients treated in services with catheteri-
zation facilities [12].
Current professional knowledge at the time of our study
(2002-5) included the need to distinguish between
ST-segment elevation myocardial infarction (STEMI)
and non-ST-segment elevation myocardial infarction
(NSTEMI), because of their different prognosis; the need
for reperfusion as quick as possible, by PCI where possible
or by thrombolysis otherwise; and, the safety of transport
of patients from community to tertiary hospitals [13-15].
Changes in definition and the diversity of the various
cardiac troponin assays may have heavily affected AMI
incidence rates and AMI-CFRs [16-20].
A tt h et i m et h es t u d yd a t aw e r er e g i s t e r e da n dc o d e d
by the hospitals, the International Classification of Dis-
eases, Ninth Revision, Clinical Modification (ICD-9-CM)
did not distinguish between STEMI and NSTEMI, but
as from October 2005 new ICD-9-CM regulations pro-
vide guidance to do so [21]. Herein STEMI is coded as
410.0-6, 410.8; NSTEMI as 410.7; and AMI “Not Other-
wise Specified” (AMI-NOS) as 410.9. It became then
possible for one of the authors (NT) to recode a poster-
iori the data in terms of STEMI or NSTEMI.
According to the OECD “Case-fatality rates measure
the proportion of patients with a given diagnosis, here
acute myocardial infarction (AMI), who die within a
specified time period, here 30 days [11]. Ideally, the
case-fatality rates would be based on each individual
patient who would be tracked for at least 30 days. How-
ever, as most countries do not have unique patient
identifiers and lack the ability to track patients after
hospital discharge, the indicator is based on unique hos-
pital admissions and restricted to mortality within the
hospital. Thus, differences in practices in discharging
and transferring patients may influence the findings
[11]“. Due to the specifics of our administrative data
and in alignment with the Agency for Healthcare
Research and Quality (AHRQ) definition of the Acute
Myocardial Infarction Mortality Rate, our definition of
AMI-CFR is exclusively based on hospitalized cases and
fatalities within the hospital regardless of any time con-
straint [9,22].
A fair inter-hospital comparison requires high-quality
data [23,24]. Indeed, they have to be sufficiently detailed
to allow fair comparison between a hospitals’ practices
and the then professional knowledge but also to assess
the hospitals’ organizational performance, especially its
transfer policy and the symptom-onset-to-balloon time
[25]. Risk-adjustment constitutes a constant threat to
the fairness of the comparisons and widely used proprie-
tary risk-adjustment systems may lead to erroneous con-
clusions [26,27].
Accountability of caregivers and health authorities to
the community is internationally considered of para-
mount importance [28]. In spite of known limitations,
public reporting of comparative information about the
quality of health care, often derived from administrative
data, is frequently put forward as an important quality
improvement tool, which attempts to stimulate care-
givers to grade up the provision of services and to reas-
sure patients by demonstrating accountability [29-31]. In
this context, ensuring data quality is a continuous chal-
lenge especially if the same data are used for reimburse-
ment and for measuring quality [31,32].
In an effort to encourage the hospital system to
assume responsibility, the Belgian Ministry of Public
Health decided to stimulate initiatives of quality
improvement. Hereto a limited set of indicators was
selected from the AHRQ Inpatient Quality Indicators,
including the AMI-CFR [33]. These indicators were to
be routinely analyzed, using routinely collected, Belgian
hospital discharge records that are known to differ
across institutions in quality of data [34] and recogniz-
ing that the above-mentioned differences in practices in
discharging and transferring patients may influence the
findings.
In this study we explore the AMI-CFRs’ potential as a
quality-improving tool. More precisely we aimed, by
determining the existence of inter-hospital differences in
AMI-CFR, (1) to evaluate to which extent Belgian dis-
charge records allow the assessment of quality of care in
the field of AMI, and (2) to identify starting points for
quality improvement.
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Data sources
Belgian hospitals are required to register discharge data
on each sojourn, which are processed and stored in a
dataset called the Minimal Clinical Data (MCD). The
MCD contains patient data (among which year of birth,
gender, residence, and anonymous hospital and patient
identifiers) and stay data (among which year, month and
day of the week but, due to privacy restrictions, not the
precise date of admission and discharge; length of stay;
transfer to another hospital with specification of the
type of hospital). It further includes an unbounded
number of ICD-9-CM coded diagnoses and procedures
but neither results of laboratory investigations, such as
cardiac enzymes, nor of technical examinations such as
electrocardiograms. Due to privacy regulations a unique
identifier, allowing for follow-up of a transferred patient,
is lacking. Nonetheless, these data allow for the identifi-
cation of a cardiogenic shock, the most feared complica-
tion of AMI, as well as for the computation of the
Charlson co-morbidity index (CCI) (see additional file 1:
Charlson), particularly well suited to study AMI-CFRs
[2,20,35-37].
Incompleteness and inaccuracy are well-known draw-
backs of administrative data; therefore, we compared the
MCD data with those from the Ghent and Bruges regis-
tries for acute coronary events, which are collected accord-
ing to the protocol that was originally developed in the
WHO Multinational Monitoring of Trends and Determi-
nants in Cardiovascular Diseases (MONICA) project
[16,38] (see additional file 2: MONICA definitions). In this
project the record form is intentionally kept as simple as
possible [38]. It consists of (1) items characterizing the
person (date of registration, gender, date of birth and data
of onset of the acute attack) and of (2) medical and diag-
nostic data (whether it was an hospital case or managed
elsewhere; whether it was a first or a recurrent event;
whether the patient survived at 28 days or not; determina-
tion of the diagnostic category based on symptoms, elec-
trocardiograms, serum enzymes and necropsy findings). In
addition, the registries of Ghent (covering the city of
Ghent (about 250,000 inhabitants)) and Bruges (covering
the district of Bruges (about 260,000 inhabitants)) record
whether or not a revascularization procedure (PTCA or
thrombolysis) was carried out. Coding of all items is
checked by both external and internal quality control [38].
In the light of these uniform registration practices and
the quality control carried out, we consider the MON-
ICA registries the standard against which we evaluated
the MCD.
For the years 2002-2004 and for the age groups
between 25 and 74 years, we compared the MONICA
hospitalized fatalities (fatal definite (F1) + fatal possible
(F2)), the numerator of the AMI-CFR, and MONICA
hospitalized cases (non-fatal “definite” (NFl) + “possible”
(NF2) + fatal “definite” (F1) + “possible” (F2)), the
denominator of the AMI-CFR, with respectively
the AMI fatalities and cases in the same age groups of
the MCD. Unlike the AHRQ definition, a case fatality in
MONICA is defined as death within 28 days after the
occurrence of the first symptoms [38]. In the framework
of routine analyses of the MCD, for reasons of monitor-
ing over the years, and to comply with the OECD
requirements, we preferred to stay in line with the
AHRQ model, adopted by the OECD, recognizing
the difference in definition of in hospital AMI-CFR
between MCD and MONICA. However in Belgium, this
difference leads to the very small 0.5% difference in
AMI-CFR [39].
Due to privacy regulations and according to the agree-
ment with the hospitals not to perform any analysis on
hospital level, we were unable to compare both data-
bases neither on a hospital nor on an individual level.
However, to formally assess the completeness of the
data we intended to compare on register level the num-
ber of cases as well as the case-fatality rates of the
Ghent and Bruges registries with the corresponding
MCD. To do so log-linear models were to be fitted with
the number of cases as the dependent variable, and gen-
der, place and registry as covariates. The need to include
registry as a covariate was to be examined by leaving
registry out from the explanatory variables. Fitting log-
binomial regression models [40] would allow us to
observe a possible difference in risk ratio between both
registries and MCD, implying either an underestimation
or an overestimation of case-fatality rates by the MCD.
Notice that, according to the MONICA protocol, fatal-
ities occurring within the first hour after hospitalization
were recorded by the registries of Ghent and Bruges.
Definition of the study population
Building on the work of the Agency for Healthcare
Research and Quality (AHRQ) [9] we selected, for the
years 2002-2005, from the MCD all stays having AMI as
principal diagnosis (ICD-9-CM code 410.*1, the fifth
digit indicating an initial episode of care). Cases with no
information regarding vital status at discharge or aged
less than 18 years or, to avoid double counting of
patients when computing rates, transferring-out to
another short-term hospital were excluded. We also
excluded short-term hospitals registering less than 20
cases a year. Applying these criteria we obtained our
study population consisting of 46,287 cases (30,271
males and 16,016 females) and 7,099 fatalities (3,841
males and 3,285 females), registered in 109 short-term
hospitals.
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Our aim was to identify, at the same time, hospitals with
higher quality of care, for benchmark and exemplary
function purposes, and hospitals with lower quality, to
help them improve their performance. To this effect, the
AMI-CFR of each individual hospital was compared
with the corresponding rate of the whole of the other
Belgian hospitals.
To assess hospital-specific rates of AMI-CFR a cohort
study of all hospitalized AMI cases of the years 2002 to
2005 was carried out. Hereby, two types of analyses
were performed: a global one focusing on the AMI-
CFRs of the entire time span of the study (the “period”)
and a temporal one (the “trend”), focusing on its per-
semester evolution and intended to refine the initial,
global assessment by taking temporal evolution into
account.
It has been suggested that in analyses, founded on
administrative databases, confounding effects of unmea-
sured or mismeasured variables can be equivalent in
magnitude to the effect of the association of interest
and cannot be ruled out as an explanation of rather
small, yet statistically significant effect sizes, such as a
relative risk (RR) of, say, 0.75 to 1.35, which are roughly
each other’s inverses [41]. To take this caution against
over-interpretation into account, we defined an incon-
clusive zone, where the AMI-CF rate or AMI-CFR trend
of a hospital, compared with these of the other hospi-
tals, should not be interpreted as being “higher” or
“lower,” but rather be considered “inconclusive.” First,
we computed a hospital’s relative risk (RR) of having a
higher/lower period or trend AMI-CFR than those of
the other hospitals. Subsequently, this RR allowed us to
calculate a “departure,” equaling (RR-1) × 100, which we
used to define an “inconclusive zone.” Regarding the
period, we fixed the lower and upper boundaries of the
inconclusive zone at a departure of - 25% and of + 35%,
respectively, in line with the aforementioned relative
risks. In the absence of literature regarding important
departures of the trend, we arbitrarily fixed these
boundaries at - 5% and + 5%, allowing for a maximal
increase of + 41% or for a maximal decrease of -30%,
respectively, of the AMI-CFR during the entire time
span of the study. The technical details of our approach
are described in the paragraph devoted to the statistical
analysis.
The results of the analyses regarding hospitals outside
the inconclusive zone, were interpreted according to the
degree of statistical evidence. We labeled this evidence
as: 1) “strong,” if the probability of finding a departure,
as important or bigger than that of the hospital under
consideration, was smaller than or equal to 0.05 divided
by the number of hospitals to be compared (the so-
called Bonferroni correction for multiple comparisons
[42]); 2) “moderate,” if this probability was smaller than
or equal to 0.05 but greater than 0.05 divided by the
number of hospitals to be compared; 3) “weak,” other-
wise [34]. For both the period and the trend analyses,
t w oA M I - C F R sw e r ec o m p u t e d :af i r s to n ei nw h i c h
transferring-out cases are excluded, so as not to com-
pute national rates with duplicate observations [9], and
a second one in which all transferred cases are excluded,
to allow for a comparison between hospitals in the sub-
set of cases they treated from uptake to discharge.
We also aimed at identifying transferred patients using
composite keys consisting of a patient’sy e a ro fb i r t h ;
gender; residence; year and month of admission and dis-
charge; and day of the week of discharge ("discharge”
facility’s data) or admission ("intake” hospital’s data). In
these patients, we intended to compare the CCI distri-
butions before and after transfer to evaluate the com-
parability across hospitals regarding the coding of
co-morbidity, a component of the risk-adjustment in
our regression analyses. From the viewpoint of quality
o fc a r e ,w ea l s oc o m p a r e di nt h e s ep a t i e n t st h et i m e
span between admission and transfer with the then pre-
vailing guidelines.
Statistical methods
For our analyses, we used so-called fixed-effects models,
motivated by the fact that the entire population of Bel-
gian hospitals is considered, rather than sampling from
them. We performed multivari a b l el o g i s t i cr e g r e s s i o n s
[43], aiming to identify outlying hospitals, i.e. character-
ized by an important and statistically significant, Bonfer-
roni-corrected [24] departure from the other hospitals’
AMI-CF rate or AMI-CFR evolution over time. Given
that we cover the short time span of only eight seme-
sters, we merely fitted models with a linear time trend,
which for brevity we called “trend”. By incorporating an
interaction term in the logistic regression between a lin-
ear time trend, expressed in semesters, and individual
hospitals, those hospitals with an abnormal evolution in
time were identified. Precisely, we compared the slope
of each hospital’s time trend with that of the other hos-
pitals using linear contrasts.
When the outcome of interest, such as the percentage
of fatal cases in the AMI case fatality rate, exceeds 10%,
or if the odds ratio is greater than 2.5 or less than 0.5,
the estimation of the relative risk by the adjusted odds
ratios, derived from the logistic regression no longer
adequately approximates the relative risk, which may
become heavily biased. Indeed, the more frequently that
outcome occurs, the more the odds ratio overestimates
the relative risk when it is greater than 1 or underesti-
mates the relative risk when the odds ratio is less than
one [44]. To reduce this bias, we used the approxima-
tion of the RR by Zhang [44], which has been used to
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between RRZ and the odds ratio is given by RRZ =O R /
((1-P0) + (P0 *OR), where P0 indicates the incidence of
the outcome of interest in the non-exposed group [44].
Following the AHRQ model [22], we carried out two
types of main analyses: a first one wherein transferred-
out cases were excluded and a second one with exclu-
sion of all transferred cases. In each analysis, adjustment
was made for five-year age groups, gender, per-semester
evolution of the AMI-CFRs, and shock.
To account for correlation within the data, rescaling
techniques were used [45]. To study a possible national
upward trend we used so-called Generalized Estimating
Equations (GEE), a refinement of the logistic regression
that corrects for within-hospital, generally within-unit,
correlation [46].
Feedbacks
The results of the analysis serves two purposes: feedback
to the hospitals to enable improvement of care, and
feedback to the Belgian College of Physicians to identify
hospitals with “strong” evidence of either superior or
inferior quality.
The feedback to the hospitals consists mainly of (1) a
graphical display of the “departure” of each of the hospi-
tals from the rate and trend of the other hospitals, and
(2) an anonymous and tabular representation of these
departures as well as of an indication of the level of sta-
tistical evidence. An aid in the interpretation, combining
the information of both the period and trend analyses, is
provided alongside. Its decision tree is given in the
Appendix of the Supplementary Materials (see addi-
tional file 3: decision tree).
In the feedback to the Belgian College of Physicians,
we present an “Average” and two “Outlying” categories
of hospitals. For the period analysis, a first, outlying
category, the ‘high AMI-CFR’ group, consists of those
hospitals with a departure of >+35% and statistically sig-
nificant (Bonferroni-corrected). A second, outlying cate-
gory, the ‘low AMI-CFR’ group, consists of those
hospitals with a departure of <-25% and statistically sig-
nificant (Bonferroni-corrected). The other hospitals are
grouped into the ‘average AMI-CFR’ group. A similar
approach is followed regarding the trend, with bound-
aries at +5% and -5%.
The decision tree is identical to that, used in the feed-
back to the hospitals, except that hospitals recommended
for an external audit are now divided in “high AMI-CFR”
and “low AMI-CFR” groups and that the other hospitals
are regrouped in an “average AMI-CFR” group.
Sensitivity analyses
Due to the prognostic differences, related to the type of
AMI, its complications and treatment modalities, several
sensitivity analyses were carried out. After an initial ana-
lysis, modeling AMI-CFR adjusted for age, gender, CCI
and time (period as well as trend), subsequent analyses
were carried out, consecutively introducing a variable
mentioning whether shock was present at admission or
not, and a variable indicating whether or not an angio-
plasty had been performed. We repeated the subsequent
analyses, this time replacing shock by a variable describ-
ing the type of AMI i.e. STEMI, NSTEMI or AMI NOS.
We performed these analyses twice: firstly after exclu-
sion of the transferred-out cases and subsequently after
exclusion of all transferred cases. In the trend analyses,
we additionally modeled an interaction term between
trend and individual hospitals. To summarize the effect
of including additional explanatory variables into the
model, we classified for each model the hospitals into
seven categories, ranging from strong, then moderate, to
weak evidence of finding themselves above or below the
inconclusive zone.
A last category consisted of hospitals showing no
interpretable departure.
In so doing, we were able to compare between the
hospitals their changes of category due to the modeling
process. Because differences in hospitals’ discharge pol-
icy may influence their AMI-CFRs we also compared
the hospitals’ cumulative AMI-CFR at five points in
time, namely at the 7th, 14th, 21st, and 28th day of hos-
pitalization, and at the latest day of discharge of any
AMI-case [11]. Given the changing numerators of the
rate over time, we based our comparison on the hospi-
tals’ change in deciles of AMI-CFR. To this end, we
computed a maximum change in relation to the initial
AMI-CFR. We further determined for each hospital the
maximum length of stay (LOS) of any patient whether
deceased or not, and the maximum LOS of any
deceased patient, both after exclusion of the transfer-out
cases and after exclusion of all transferred cases.
To provide an idea of the variability of some major
covariates we determined across hospitals and by level
of care, averages of the lower quartile, mean, median
and upper quartile of the CCI, LOS and rate of shock.
In the same way we computed the average 95th CCI-
percentile and the ranges of the LOS.
The study being (1) of a retrospective, non-interven-
tional type and (2) anonymous with respect to both hos-
pitals and patients, no approval by an ethics committee
is required under the Belgian law.
Results
Patient and hospital characteristics by level of care
The MCD dataset consisted of 46,287 cases and 7,099
fatalities [AMI-CFR: 15.34 (95% CI: 15.01;15.67) from
109 hospitals. The majority of cases (65,4%) and of the
fatalities (54.1%) were males. In females the AMI-CFR
Aelvoet et al. BMC Health Services Research 2010, 10:334
http://www.biomedcentral.com/1472-6963/10/334
Page 5 of 15was higher than in males [age-adjusted OR: 1.13 (95%
CI: 1.04; 1.22)]. In tertiary hospitals, younger age groups
(Pearson chi-square with 10 df = 794.7; p < 0.0001),
males (Pearson chi-square with 2 df = 214.5; p < 0.0001)
and shock (Pearson chi-square with 2 df = 6.29; p =
0.043) are over-represented (Table 1).
The age-adjusted mortality was higher in Type A
[OR:1.17; 95%CI(1.09;1.26)] hospitals than in Type B2-B3
hospitals. However, we were unable to establish a signifi-
cant difference in age-adjusted mortality between Type A
en Type B1, and between Type B1 and Type B2-B3 hos-
pitals (Table 1). Males had lower mortality figures than
females [OR:0.58; 95%CI(0.55;0.61)]. The sex-adjusted
mortality was higher in Type A [OR:1.37; 95%CI
(1.30;1.45)].and Type B1[OR:1.18; 95%CI(1.10;1.27)] hos-
pitals than in Type B2-B3 hospitals. Type A hospitals
also displayed a higher sex-adjusted odds ratio [OR:1.16;
95%CI(1.08;1.26)] than Type B1 (Table 1).
Type B2-B3 hospitals had a lower CFRs in case of car-
diogenic shock {(ORAvsB2-B3:1.14 [95%CI(1.23;1.67)] and
ORB1vsB2-B3:1.89 [95%CI(1.51;2.21)])}, and Type A hos-
pitals also had a lower CFR than Type B1 (ORAvsB1:0.76
[95%CI(0.60;0.96)]). Type B2-B3 hospitals had also a
lower CFRs in case of absence of cardiogenic shock
{ORAvsB2-B3:1.70 [95%CI(1.58;1.82)] and ORB1vsB2-
B3:1.32 [95%CI(1.20;1.45)] }, but now Type A hospitals
had a higher CFR than Type B1 (ORAvsB1: 1.29 [95%CI
(1.17;1.41)]) (Table 1).
With respect to STEMI cases we observed higher AMI-
CFRs of Type A and B1 versus Type B2-B3 hospitals
{(ORAvsB2-B3:1.36 [95%CI (1.27;1.47)] and ORB1vsB2-
B3:1.22 [95%CI (1.12;1.34)])} and of Type A versus Type
B1 hospitals (ORAvsB1: 1.11 [95%CI (1.01;1.22)]). In
NSTEMI cases we observed substantially lower AMI-CFRs
in Type B2-B3 hospitals {(ORAvsB2-B3:2.01[95%CI
(1.79;2.26)] and ORB1vsB2-B3:1.84 [95%CI (1.55;2.18)])}
(Table 1). In contrast we were unable to demonstrate
either a difference in AMI-CFR between Type A and Type
B1 hospitals or evidence of any deviating AMI-CFR in
cases of AMI-NOS. The proportions of cardiogenic shock
were very high, viz 9.9% in STEMI, 4.2% in non-STEMI
infarctions and even 12.7% in the AMI NOS group.
On the hospital level we noticed huge variability
across institutions of the same type regarding CCI,
length of stay and to a lesser extent shock (expressed in
%). However the distribution of these variables was very
similar in the three types of hospitals (data not shown).
We also observe a huge variability in volume, i.e the
number of cases, within and between types of hospital
(Table 1). Based on the volumes of the lower quartile,
the median and the upper quartile of the Type B1 hos-
pitals in the data, transfers out excluded, we grouped
the hospitals in four classes. We observed a huge varia-
bility in volume between and within Types of hospital
(Pearson chi-square of 300019 with 6 df;p < 0.0001)
with excesses of low volume hospitals in Type A hospi-
tals (41 out of the 61 of these hospitals found them-
selves in the lowest class) and of high volumes in Type
B2-B3 hospitals (26 out of the 29 of these hospitals
found themselves in the highest class). The Type B1
hospitals were almost equally distributed over the four
classes. Similar findings were encountered in the analy-
sis on the data with exclusion of all transfers.
Comparison between MCD and MONICA
The comparison of the MCD with MONICA (Ghent
and Bruges) shows important differences between both
datasets (Table 2), characterized by more fatalities and
significant higher case-fatality rates in the MONICA
registry. Notice that in the MONICA registry 54 out of
the 190 fatal cases occurred within the first hour after
hospitalization. At that moment these patients probably
found themselves in the emergency services, where in
Belgium as yet no specific ICD codes are systematically
registered. Regarding the number of cases, we were
unable to determine a significant difference between
both datasets, the difference in the Pearson chi-squared
statistics of our log-linear models being not significant
(p = 0.19). Conversely, we observed a significant differ-
ence in risk ratio implying an important underestima-
tion of case-fatality rates by the MCD (RR:0.39[95%
CI:0.31;0.51]). However in the absence of a significant
interaction term between registry and place (p = 0.82)
we were unable to establish a differential underestima-
tion according to place. Leaving out the fatalities occur-
ring within one hour after admission led to similar
results.
Notice that the number of (mortality) cases registered
in the MCD alternately was larger or smaller than those
of MONICA.
We were also able to compare PTCA figures between
MONICA and MCD. For the years 2002-4 MONICA-
Ghent registered 83 PTCAs in males and 19 in females
versus respectively 102 and 20 PTCAs in the MCD. For
Bruges these numbers amounted to 87 and 20 in MON-
ICA versus 149 and 30 in the MCD. We paired the data
and computed their proportions as well as the corre-
sponding 95% confidence interval [47]. Apart from the
numbers for females in Ghent, the MCD numbers of
PTCA exceeded significantly (the lower bound of the CI
being ≥1) those of MONICA.
For the same years we also compared the recurrent
events registered in MONICA with the AMI cases in
the MCD mentioning in addition an “old myocardial
infarction” (ICD-9-CM code: 412) as a secondary diag-
nosis. This exercise also showed substantial differences
between MONICA and MCD. In Ghent MONICA
totaled 53 recurrent events in males and 11 in females,
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Page 6 of 15versus 22 and 3 respectively in the MCD. For Bruges
these numbers amounted to 76 and 14 in MONICA ver-
sus 49 and 6 in Bruges. Each time the MONICA figures
significantly outnumbered (the lower bound of the CI
being ≥1) those of the MCD.
Transfers
From the MCD data, before the exclusion of transfer
cases, we identified 6,555 stays mentioning only a transfer-
in from another hospital, 12,409 stays mentioning only a
transfer-out to another hospital, and 4592 mentioning
Table 1 Patient and hospital characteristics by level of care
Level of care
Type A Type B1 Type B2-B3
Patient charateristics
Age N % CFR N % CFR N % CFR
<40 y 217 1.5 2.8 133 1.9 3.8 508 2.1 4.7
40-59 y 988 6.7 5.6 656 9.1 3.8 2,331 9.6 4.3
50-59 y 2,047 13.9 6.4 1,226 17.1 6.0 4,721 19.4 4.7
60-69 y 2,643 18.0 10.2 1,242 17.3 10.1 5,13 21.0 8.7
70-79 y 4,165 28.3 19.0 1,971 27.4 16.2 6,705 27.5 15.4
80 y+ 4,641 31.6 30.5 1,959 27.3 30.6 5,004 20.5 29.2
Gender
Males 9,095 61.9 15.2 4,475 62.3 12.7 16,708 68.5 11.3
Females 5,606 38.1 22.9 2,712 37.7 21.4 7,691 31.5 18.1
Total 14,701 18.1 7,187 16.0 24,399 13.5
Shock
Present 1,313 8.9 75.5 611 8.5 80.2 2,294 9.4 68.2
Absent 13,388 91.1 12.5 6575 91.5 10.0 22105 90.6 7.8
Type of AMI
STEMI 1,497 63.0 16.18 775 73.1 14.76 2,036 67.3 12.39
NSTEMI 251 14.2 7.48 88 9.5 7.03 366 13.0 7.61
AMI NOS 917 22.8 43.9 285 17.4 41.67 884 19.7 27.97
Hospital characteristics
Number 61 19 29
Volume 2002-5,
transfers out excluded
Minimum 95 239 312
Lower quartile 149 277 584
Median 194 355 776
Mean 241 378 841
Upper quartile 309 487 1122
Maximum 817 660 1596
Volume 2002-5,
all transfers excluded
Minimum 69 133 292
Lower quartile 123 200 484
Median 174 265 685
Mean 201 281 708
Upper quartile 249 332 801
Maximum 798 542 1448
Patient characteristics:
N: number of cases; %: column percentage; CFR: AMI-CFR in %
STEMI: ST-segment elevation myocardial infarction; NSTEMI: non-ST-segment elevation myocardial infarction; AMI NOS: AMI not otherwise specified.
Level of care: community hospitals (labeled A) having no catheterization facility, intermediary hospitals (labeled B1) providing coronary angiography but no
Percutaneous Coronary Intervention (PCI), and tertiary hospitals (labeled B2-B3) offering PCI and/or Coronary Artery Bypass Graft.
Hospital characteristics:
Minimum, Maximum: minimum and maximum number of observations per type of hospital
Lower quartile, Median, Mean, Upper quartile: percentiles of the distribution of the number of observations per type of hospital
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to pair respectively 2,524, 4592 and 2657 transfers.
In the subset of 2,524 paired transfer-in stays, we also
assessed the accuracy of our co-morbidity data. The first
quartile, median and third quartile of the distribution of
the CCI amounted to 0, 0 and 2 in the “discharging”
and to 0,1 and 2 in the “intake” facilities respectively.
We also determined the time of referral, which in over
50% of the cases exceeded 24 hours.
Sensitivity analyses
In 27 hospitals neither the adjustments used nor the
stays excluded according to type of transfer, altered the
category of evidence to which they belonged. In 45 hos-
pitals the change did not exceed 2 categories; in 31 hos-
pitals the change equaled 3 categories, without crossing
the overall rate; and, in 5 tertiary hospitals the change
amounted at least to 3 categories and crossed the overall
rate. In the latter cases poorer AMI-CFRs were found
when adjustment was made for shock or STEMI and for
carrying out an angioplasty.
The range of the point estimators of the departures
was considerable and varied substantially across the
fitted models (Table 3).
In a first series of analyses, wherein transferred-out
cases, were excluded, the cumulative AMI-CFR, adjusted
for age, gender, CCI and shock, showed a huge inter-
hospital variability in AMI-CFR over time. The maxi-
mum change in deciles amounted to 0, 1, 2, 3 and 4 or
5 deciles in 21, 49, 25, 12 and 2 hospitals respectively.
Analogously, after exclusion of all transferred cases, a
m a x i m u mc h a n g ei nd e c i l e so f0 ,1 ,2 ,3 ,4o r5w a s
observed in 24, 58, 15, 11 and 1 hospitals, respectively.
Similarly, excluding the transferred-out cases, we
observed across hospitals ranges of the maximum LOS
of any patient from 36 to 337 days and from 12 to 233
days in deceased patients. Very similar ranges from 36
to 243 days and from 12 to 232, respectively, were
obtained after exclusion of all transferred cases.
Determinants and evolution of the national AMI-CFR
Shock (adjusted ORs of 23.0[95%CI: 20.9;25.2] and of
21.0 [95%CI: 19.0;23.2]) proved to be by far the stron-
gest determinant of AMI-CFR in all the models, fol-
lowed by age (adjusted ORs between 1.35 and 1.37), and
severe co-morbidity (for example in the Initial model 1
a CCI of four has an adjusted OR of 1.09
4 =1 . 4 1 .
Indeed, CCI being modeled as an interval variable, an
adjusted odds ratio between successive levels of CCI
equals 1.09.) (Table 4). The adjusted odds ratios of gen-
der and trend, although statistically significant, found
themselves in the inconclusive zone.
Table 2 Comparison MCD and MONICA (districts of Bruges and Ghent); 2002-4
Bruges 2002-2004 Ghent 2002-2004
Females Females
Fatal Total Fatal Total
Age MONICA MCD MONICA MCD MONICA MCD MONICA MCD
<1 h° ≥1 h° Subt.°° <1 h ≥1 h Subt.
2 5 - 3 4 y 0 0 0 001 0 0 0 023
3 5 - 4 4 y 0 0 0 046 0 0 0 032
45 - 54 y 0 1 1 1 12 10 1 2 3 2 18 13
54 - 64 y 0 6 6 1 23 23 5 4 9 2 29 28
65 - 74 y 5 14 19 6 71 65 6 11 17 5 59 54
Total 5 21 26 8 110 105 12 17 29 9 111 100
Males Males
Fatal Total Fatal Total
Age MONICA MCD MONICA MCD MONICA MCD MONICA MCD
<1 h ≥1 h Subt. <1 h ≥1 h Subt.
2 5 - 3 4 y 0 0 0 011 0 0 0 043
35 - 44 y 0 0 0 0 23 20 0 2 2 1 34 29
45 - 54 y 2 7 9 3 104 89 4 3 7 4 87 95
54 - 64 y 1 10 11 4 117 114 8 22 30 11 112 109
65 - 74 y 9 31 40 12 162 141 13 23 36 19 137 138
Total 12 48 60 19 407 365 25 50 75 35 374 374
°: </≥1 hour: number of fatal cases having sojourned less than/at least one hour at the hospital before dying. This item is only registered in the MONICA registry;
the MCD merely provides the day of decease without indicating whether the event took place within the first hour of admission or later on in the hospital stay.
°°:Subt.: subtotal (MONICA registry): number of fatal cases having sojourned at least one hour at the hospital before dying and of the number of fatal cases
having sojourned less than one hour at the hospital before dying
MCD: Minimal Clinical Data; MONICA: Monitoring of Trends and Determinants in Cardiovascular Diseases register
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We observed substantial and statistically significant
inter-hospital differences in AMI-CFRs, both in the per-
iod and the temporal analysis, based on a model with
age, gender, CCI and shock as explanatory variables.
These differences arose in both the models with exclu-
sion of transferred-out cases and those wherein all
transferred cases were excluded. From the model
wherein all transferred cases were excluded, we repre-
sented in Figure 1 the Bonferroni-corrected, outlying
hospitals by green diamonds ("high”)o rb l u ec i r c l e s
("low”) and the other hospitals by red squares ("aver-
age”). Departures ranged from -65% up to +196% in the
period, and from -47% up to +39% in the trend analysis,
resulting in seven “high AMI-CFR” and nine “low AMI-
CFR” outlying hospitals in the period and one “high
AMI-CFR” and three “low AMI-CFR” outlying hospital
in the trend analysis. For the model with exclusion of
transferred-out cases, we observed departures ranging
from -60% to +185% in the period and from -45% to
+30% in the trend analysis, resulting in four “high AMI-
CFR” and eight “low AMI-CFR” outlying hospitals in the
period and one “high AMI-CFR” and one “low AMI-
CFR” outlying hospital in the trend analysis.
The same analyses, performed on the subset of tertiary
level hospitals, also showed marked and statistically sig-
nificant inter-hospital differences in AMI-CFRs in both
models. In the model with transfer-out cases excluded,
the departures in the period analysis ranged from - 36%
to +70%, resulting in two “high AMI-CFR” and one “low
AMI-CFR” outlying hospitals. In the trend analysis no
significant departures were observed. In the model with
all transfers excluded we observed one “high AMI-CFR”
outlying hospital in the period analysis (departure +60%)
and one “low AMI-CFR” outlying hospital in the trend
analysis (departure - 14%).
According to type of cardiac care provided, we found
important, i.e. beyond the inconclusive zone, and statis-
tically significant differences between community and
tertiary level hospitals, except for “Initial 1 model”
(Table 4) where, in spite of a statistical significant differ-
ence, no firm conclusion could be made, the excess
being situated in the inconclusive region. The differ-
ences between intermediary and tertiary level hospitals
fell outside the inconclusive zone for the models
wherein all transfers are excluded { model “Initial 2":
ORB1vsB2-B3:1.38 [95%CI (1.25;1.52)]) and model “Shock
2” ORB1vsB2-B3:1.48 [95%CI (1.33;1.65)])} (Table 4).
The fitted models showed very good discrimination
properties reflected by areas under the receiver operating
characteristic (ROC) curves between 0.74 and 0.85 [48].
Discussion and Conclusions
Data quality of the MCD
Our results suggested numerous quality-of-data-related
problems and prompted a very cautious interpretation
Table 3 Range of the point estimators of the “departures” according to the fitted model
I I+S h I+S h+A I+S t I+S t+A
Max Min Max Min Max Min Max Min Max Min
No transfer-out cases Period 140 -64 182 -63 152 -70 97 -59 91 -64
Trend 25 -38 30 -41 29 -42 27 -54 26 -31
All transferred cases excluded Period 153 -62 196 -65 163 -71 104 -64 84 -63
Trend 29 -42 39 -47 42 -48 30 -32 31 -33
I: initial model (age, gender and CCI); I + Sh: initial model + shock;
I + Sh + A: initial model + shock + angioplasty; I + St: initial model + STEMI;
I + St + A: initial model + STEMI + angioplasty.
Table 4 Determinants and evolution of AMI-CFR. Mutually adjusted odds ratios and 95% confidence intervals ()
Initial 1 Initial 2 Shock 1 Shock 2
Age (5-year groups) 1.37 (1.35; 1.40) 1.36 (1.34; 1.39) 1.36 (1.34; 1.39) 1.35 (1.32; 1.38)
Males 0.90 (0.84; 0.96) 0.92 (0.86; 0.99) 0.91 (0.84; 0.98) 0.93 (0.86; 1.01)
CCI 1.09 (1.08; 1.10) 1.07 (1.06; 1.09) 1.06 (1.05; 1.08) 1.05 (1.04; 1.06)
Trend (semester) 0.98 (0.96; 0.99) 0.98 (0.97; 1.00) 0.98 (0.96; 0.99) 0.99 (0.97; 1.00)
Shock . . . . . . 23.0 (20.9; 25.2) 21.0 (19.0; 23.2)
Community vs tertiary 1.21 (1.12; 1.30) 1.47 (1.37; 1.59) 1.39 (1.28; 1.50) 1.61 (1.48; 1.75)
Intermediary vs tertiary 1.08 (0.99; 1.19) 1.38 (1.25; 1.52) 1.23 (1.11; 1.36) 1.48 (1.33; 1.65)
AMI-CFR: Acute myocardial infarction case-fatality rate
Initial 1: odds ratios adjusted for age, gender, CCI, and trend (transfers-out excluded)
Initial 2: odds ratios adjusted for age, gender, CCI, and trend (all transfers excluded)
Shock 1: odds ratios adjusted for age, gender, CCI, trend, and shock (transfers-out excluded)
Shock 2: odds ratios adjusted for age, gender, CCI, trend, and shock (all transfers excluded)
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Page 9 of 15of the quality-of-care-related findings. At first, AMI is
characterized by diagnostic uncertainty, manifesting
itself in marked differences in sensitivity and specifi-
city of the measurement of myocardial proteins, ECG
recordings and imaging modalities [18,49]. This may
be reflected by the denominator differences of the
AMI-CFR we found between the MCD and MONICA
data. Part of these differences is probably due to the
absence of national guidelines leaving the choice of
the diagnostic criteria to the individual clinicians,
whereas in MONICA univocal diagnostic criteria were
used. In a German study [50], similar to ours, the hos-
pital’s AMI-CFR amounted to 13.5% versus the 28%
derived from the German MONICA data, whereas in
ours these rates amounted to 7.5% and 19,0%,
respectively.
 
dl i dl i i h i l i
Figure 1 Inter-hospital differences in AMI-CFR, period (upper part of the figure) and trend (lower part of the figure), all transfers
excluded. Belgium 2002-5. Dotted lines delimit the inconclusive zone. Hospital id: anonymous hospitals’ identification number.
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unfortunately very limited, due to privacy and agree-
ment regulations, shed light on other quality-of-data
problems. The outnumbering in PTCA of the MCD
may illustrate the need of univocal definitions of AMI
and coding practices and may reflect the propensity of
administrative data for maximizing coding. By contrast
the deficient registering of old myocardial infarctions,
which is financially not rewarding in our prospective
payment based reimbursement of the hospitals, comes
as no surprise.
W ea l s ot r i e dt oa s s e s sa sm u c ha sp o s s i b l et h eq u a l -
ity-of-data through internal comparisons. Thus and con-
trary to the findings in a recent publication stressing the
sensitivity of the CCI to coding practices [27], our com-
parison of the CCI distribution in transferred patients
did not suggest too large before-after transfer differ-
ences. However, our sensitivity analyses seemed to indi-
cate a sizable inter-hospital variability in the accuracy of
the data.
The completeness of the data also was a cause for
concern. Since about 50% of the fatal STEMI cases
occur in the first two hours after the onset of the symp-
toms, the under-registration of fatalities may be due to
the lack of ICD-coding of the pathologies during a stay
in an emergency department [4]. Important information
such as symptom-onset to needle-time, the time lag
between the onset of symptoms and the initiation of the
treatment, is lacking in our data, as well as pharmacolo-
gical treatment details, which are essential with respect
to quality assessment, especially in primary hospitals.
Also, although low socio-economic status (SES) is
related with lesser AMI-outcomes, we have no informa-
tion regarding SES [51].
Further, one has to take the basic tension into account
that exists between using the same data for reimburse-
ment of the hospitals and for quality improvement pur-
poses. Indeed, in the former case the purpose is to
maximize the coding of complications and co-morbid-
ities (e.g., CCI), while in the latter it is to restrict it to
conditions really affecting care [32]. Our shock data
may well illustrate this phenomenon. For example, we
observed rates of 9.9% and 4,2% in STEMI and non-
STEMI infarctions, respectively, which are substantially
higher than the 5 to 8.6% and 2.5% in the literature,
respectively, and to which, in addition, the 12.73% of the
AMI-NOS are to be added [20,37]. The doubling of the
reimbursement rate in these cases reflects the possible
financial gains through maximization, but the high CFRs
in case of cardiogenic shock seem not to indicate impor-
tant efforts of maximization.
Whereas in Belgium it is impossible to routinely
obtain 30-day mortality data of discharged patients, they
are very well comparable to the in-hospital mortality
data [39].
By contrast, the comparison with MONICA revealed a
substantial proportion of probably early fatalities not
registered in the MCD. As a result, the in-hospital AMI-
CFR may chiefly be biased in the initial phases of the
fatal process, preventing the in-hospital AMI-CFR to be
used as a reliable estimator of the population AMI-CFR.
In that respect population-based, acute coronary syn-
drome registries remain irreplaceable.
Since we were not able to assess whether the propor-
tion of unrecognized, early AMI deaths is equally dis-
tributed across hospitals, the inter-hospital comparison
may, apart from unevenly distributed, dubious coding
practices [34], be biased as well.
Statistical modeling
To achieve the fairest possible inter-hospital comparison
we performed two types of multivariable logistic regres-
sions leaving out respectively transferred-out cases, and
all transferred cases. In both types of analysis a risk-
adjustment for age, gender, CCI and cardiogenic shock
was performed. All the models had a C-index, a mea-
sure of the discriminative performance of the models, of
0.832 to 0.844, that are comparable to those obtained in
a study evaluating five risk scores (PURSUIT, GUSTO-
1, GRACE, SRI and EMMACE) for risk stratification of
acute coronary syndromes [52]. The authors of this
study conclude that simpler risk models had comparable
performance to the more complex ones [52]. The Sim-
ple Risk Index (SRI) for instance, which consists of age,
systolic blood pressure and heart rate, is very similar to
our here-mentioned model.
In our models, we kept away from inserting either
angioplasty - not to model away the effect of angioplasty
- or STEMI, because of both its correlation with cardio-
genic shock and its difficult-to-handle class of AMI-
NOS (about 13% of our study population and a case-
fatality rate of 86.2%), prone to biased analyses [53].
To maximally avoid the inclusion of iatrogenic, in-
hospital complications into the risk-adjustment, we also
preferred the CCI, based exclusively on chronic condi-
tions to widely used discharge abstract-based software,
which fail to distinguish co-morbidities from complica-
tions [26,27]. The choice of including cardiogenic shock
into the risk-adjustment is an arguable point; being
much more often a non-iatrogenic phenomenon than a
complication, we decided to incorporate it into our risk-
adjustment. Indeed a recent article devoted to cardio-
genic shock stated that MI with LV failure remains the
most common cause of CS but also that approximately
three fourths of patients with CS complicating MI
develop shock after hospital presentation of which in
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Page 11 of 15some, medication use contributes to the development of
shock [20].
Hierarchical models, usually taking the form of
so-called random-effects models, would have been an
alternative to the logistic regression approach we used.
However, outlier detection based on such models is cur-
rently methodologically underdeveloped. Indeed, the
theory dealing with outliers still has to be further devel-
oped for linear mixed models, with even less develop-
ment for non-linear mixed models [46,54]. Finally, in
the random-effects models the hospitals in the set of
data are considered a random sample from the larger
population of all hospitals, contrary to fact in our study
wherein the entire population of Belgian hospitals is
considered, rather than sampling from them.
Inter-hospital comparison
Two methods of calculating AMI lethality are included
in the AHRQ’s Inpatient Quality Indicators. The first
one (excluding transferred-out cases) ensures the inclu-
sion of all AMI patients. The second method (excluding
all transferred cases) reflected the desire of users to
have an alternative method of measuring AMI mortality
that excluded patients transferred from another hospital.
However, this approach results in the loss of transferred
AMI patients from any quality measurement. Therefore,
in order to allow both types of interpretation we pre-
sented the results obtained from both methods.
While important, the above-mentioned quality-of-data
limitations led inescapably to the question whether the
MCD were “good enough” to carry out an inter-hospital
comparison [55]. Contextual reasons including the
accountability of both the hospitals and the authorities, as
guarantors of the quality of health care, brought us to do
so as well as the conviction “that what cannot be measured
cannot be changed” [ 5 6 ] .A l s oo n eh a dt ok e e pi nm i n d
that administrative data, such as the MCD, not only are
the most accessible comparative data source for examining
all patients admitted to a hospital, but also the only ones
allowing a nationwide inter-hospital comparison with at
least a minimal risk-adjustment [56-58]. Further, the mag-
nitude of the observed inter-hospital differences in AMI-
CFRs - the highest AMI-CFR is six times higher than the
lowest - and the influence of type of hospital warrant
further inquiry. Indeed, the principal interest of our study
in this regard rests on its ability of screening substandard
or above-standard care, to be completed by a formal
assessment, and its stimulating effect on initiatives of qual-
ity improvement.
From the transfer exercise for instance we learned
that, going against the prevailing guidelines [14], a con-
siderable number of transfers was realized more than
24 hours after intake, suggesting the carrying out of an
elective rather than a rescue angioplasty. The case of the
five tertiary level hospitals, which in the sensitivity ana-
lysis showed the greatest AMI-CFR variability, may be
related to this phenomenon. Indeed, it may that these
centers frequently carry out this type of angioplasty, as
it was precisely the inclusion in the modeling process of
shock, underrepresented in this type of patients, and
angioplasty that caused the change in AMI-CFR. Since
this result appeared during the modeling process, one
may assume it not to be an artifact but rather an
expression of sub-optimal care.
Another intriguing finding, which requires elucidation,
was the apparent heterogeneity regarding AMI-CFR in
the group of tertiary level hospitals.
We further think to have gathered some evidence in
favor of PCI over other treatments. Indeed, comparing
our results with those of a previous study [12] and in
line with a Swedish study, its practice seemed to have
improved over time [12,59].
Finally, our analyses revealed important inter-hospital
differences in medical practices but do not seem to indi-
cate a systematic, early discharge practice of “patients
about to die” in any hospital, intended to diminish its
AMI-CFR. Also, the AMI-CFR of the hospital, admitting
transferred out patients, seems to be protected to a cer-
tain extent by the modeling of shock, age group, gender
and co-morbidity of this type of patients.
Nowadays, discharge records are used to compare
AMI-CFRs between countries. It may well that these
data suffer from similar limitations regarding the symp-
tom-onset to needle-time, type of AMI, and that they
are used both for reimbursement of the hospitals and
for quality improvement purposes. Furthermore, in case
of a hospital stay, taking place in more than one depart-
ment, some countries collect discharge records of these
partial stays, leading to an inflation of the denominator
of the rate. As a consequence, one should very cau-
tiously interpret differences in AMI-CFRs between
countries. The OECD for instance suggests that this
indicator should be considered in conjunction with
length-of-stay and transfer rates and recommends risk
adjustment for clinical factors [11].
Quality improvement
In a perspective of quality improvement, implementation
of evidence-based diagnostic and therapeutic practices
and outcome monitoring have been shown to gradually
improve outcomes in all types of hospitals and to
decrease between-hospital variation [60,61]. More speci-
fically, the measuring and tracking of performance is
considered relevant to physicians, hospital managers,
scientific bodies and policy-makers [62] and fit in the
shift of focus, observed in recent years, from the “no
blame” paradigm [63] to a more aggressive approach to
poorly performing caregivers [64].
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of findings in degrees of evidence by examining a hospi-
tal’s departure both over the whole time period and
over time in a perspective of improvement. Conscious
of the data limitations, we refer to “screening” rather
than “assessing” quality of care [65]. Therefore we
avoided to establish a ranking of the hospitals, in itself a
dubious technique [66], and to make our results avail-
able to the public by so-called report cards. The latter
not only have been shown not to significantly improve
composite process-of-care indicators for AMI [67] but
also to lead to a rising post-discharge mortality rate,
conceivably due to discharging patients in unstable con-
ditions [68]. Further, taking the organizational nature of
adverse events into account, we provided an anonymous
feedback to the clinicians, the hospital management, the
Belgian College of Cardiologists and the policymakers.
As an input for the College of Cardiologists, we aimed
at identifying the few, biggest outliers, which constitute
an operationally manageable group to scrutinize with
respect to the putative superior or substandard quality
of care provided, and to propose corrective measures if
necessary. Not outlying hospitals, displaying substantial
departures, are suggested to proceed to an internal
audit. Conversely, in our opinion it is more efficient to
advise the vast majority of hospitals, finding themselves
in the inconclusive zone, to comply with updated evi-
dence-based guidelines.
To conclude, we are of the opinion that administrative
data may provide hospitals and policy makers with
enough evidence to encourage quality improvement
initiatives. However, to measure progress it will be
necessary to (1) routinely assess and assure the comple-
teness and accuracy of the data; (2) to have univocal
case definitions; and (3) to be able to trace patients
across hospitals.
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